Overall Technical outlook

Price Summary

Gland Pharma Limited's stock opened at 1678.9 on 2025-12-15, surged to 1680.0, hit a low of 1656.9, and closed up -0.54% at 1669.8, with 25757 shares traded.
Over the past year, the stock's highest price was 2102.1, and its lowest was 1392.8.
The price projection is between 1680.0 and 2360.0, with an average expected price around 2007.8334, according to 12 analysts.

Technicals


Aroon: Aroon's bearish trend continues, with Aroon Down remaining fixed at the 100 level. This indicates strong downward momentum for GLAND, but further analysis with other indicators is essential to fully comprehend the trend's potential impact.
GLAND aroon 46d50b
Aroon chart for Gland Pharma Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position for Gland Pharma Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
GLAND bbands 46d50b
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR maintains a bearish outlook for GLAND, establishing a key resistance level that could limit further gains. This ongoing bearish trend suggests that the market may struggle to overcome this resistance, keeping upward movement subdued.
GLAND psar 46d50b
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The Stochastic K-line has fallen below the D-line and remains under the 20 mark, indicating a mildly bearish signal. This suggests that the market may experience some downward pressure, but the overall bearish sentiment is not yet strong. Investors should be cautious, watching for further developments that could confirm this trend.
GLAND stoch 46d50b
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: A bullish trend is indicated by the alignment of the 20-50-100 period moving averages for GLAND, but this strength is tempered by the slopes of the faster averages, which hint at a possible reversal. The overall trend remains positive, yet the weakening signals from the shorter-term averages suggest that a change in direction may be imminent.
GLAND trippleSMA 46d50b
Tripple SMA chart for Gland Pharma Limited


Before diving into the technical aspects of a company, such as stock price charts or volume trends, it's important to understand its fundamentals. These fundamentals include financial stability, growth potential, and strategic positioning. Additionally, knowing the broader industry landscape, including competitive pressures and regulatory factors, offers deeper insights. When this fundamental analysis is combined with technical indicators, it leads to more informed, accurate evaluations of the company's overall performance.